Wilson; Noel S.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Wilson; Noel S..The latest application filed is for "bicyclic pyrazole bruton's tyrosine kinase inhibitors".
- Wilson; Noel S. - Kenosha WI
| Patent | Date |
|---|---|
| Bicyclic Pyrazole Bruton's Tyrosine Kinase Inhibitors App 20220213092 - DeGoey; David A. ; et al. | 2022-07-07 |
| Primary Carboxamides As Btk Inhibitors App 20210179556 - Bonafoux; Dominique ; et al. | 2021-06-17 |
| Primary Carboxamides As Btk Inhibitors App 20190284135 - Bonafoux; Dominique ; et al. | 2019-09-19 |
| Heterocyclic Kinase Inhibitors App 20190135836 - Friedman; Michael ; et al. | 2019-05-09 |
| Heterocyclic kinase inhibitors Grant 10,280,184 - Friedman , et al. | 2019-05-07 |
| Indazolones as modulators of TNF signaling Grant 10,273,238 - Breinlinger , et al. | 2019-04-30 |
| Tricyclic modulators of TNF signaling Grant 10,266,532 - Breinlinger , et al. | 2019-04-23 |
| Indazolones as modulators of tnf signaling Grant 10,160,748 - Argiriadi , et al. Dec | 2018-12-25 |
| Modulators Of 5-ht Receptors And Methods Of Use Thereof App 20180346484 - Akritopoulou-Zanze; Irini ; et al. | 2018-12-06 |
| Indazolones As Modulators Of Tnf Signaling App 20180215764 - Breinlinger; Eric C. ; et al. | 2018-08-02 |
| Tricyclic Modulators Of Tnf Signaling App 20180179198 - Breinlinger; Eric C. ; et al. | 2018-06-28 |
| Indazolones As Modulators Of Tnf Signaling App 20180086737 - Argiriadi; Maria ; et al. | 2018-03-29 |
| Modulators of 5-HT receptors and methods of use thereof Grant 9,879,033 - Akritopoulou-Zanze , et al. January 30, 2 | 2018-01-30 |
| Primary Carboxamides As Btk Inhibitors App 20170174624 - Bonafoux; Dominique ; et al. | 2017-06-22 |
| Heterocyclic Kinase Inhibitors App 20170114077 - FRIDEMAN; Michael M. ; et al. | 2017-04-27 |
| Primary carboxamides as BTK inhibitors Grant 9,567,339 - Bonafoux , et al. February 14, 2 | 2017-02-14 |
| Indazolones As Modulators Of Tnf Signaling App 20160304496 - Argiriadi; Maria ; et al. | 2016-10-20 |
| Modulators Of 5-ht Receptors And Methods Of Use Thereof App 20160096851 - Akritopoulou-Zanze; Irini ; et al. | 2016-04-07 |
| Modulators of 5-HT receptors and methods of use thereof Grant 9,187,483 - Akritopoulou-Zanze , et al. November 17, 2 | 2015-11-17 |
| Primary Carboxamides As Btk Inhibitors App 20150005279 - Bonafoux; Dominique ; et al. | 2015-01-01 |
| Modulators of 5-HT receptors and methods of use thereof Grant 8,846,951 - Akritopoulou-Zanze , et al. September 30, 2 | 2014-09-30 |
| Furo[3,2-d]pyrimidine compounds Grant 8,551,981 - Calderwood , et al. October 8, 2 | 2013-10-08 |
| Novel Tricyclic Compounds App 20120330012 - Frank; Kristine E. ; et al. | 2012-12-27 |
| FURO[3,2-d]PYRIMIDINE COMPOUNDS App 20120122846 - Calderwood; David J. ; et al. | 2012-05-17 |
| Modulators Of 5-ht Receptors And Methods Of Use Thereof App 20110118231 - Akritopoulou-Zanze; Irini ; et al. | 2011-05-19 |
| Modulators Of 5-ht Receptors And Methods Of Use Thereof App 20100298292 - Akritopoulou-Zanze; Irini ; et al. | 2010-11-25 |
| Agonists and Antagonists of the S1P5 Receptor, and Methods of Use Thereof App 20100216762 - Harris; Christopher M. ; et al. | 2010-08-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 